January 24, 2021
General News

Brazil researchers report disappointing 50.4% efficacy for CoronaVac

25

This post was originally published on this site

A coronavirus vaccine developed by China’s Sinovac showed “general efficacy” of 50.4% in a late-stage trial in Brazil, researchers said on Tuesday, barely enough for regulatory approval and far short of earlier indications.

Post Gallery

logo news for finance

Newsforfinance.com is an online news aggregator website. We collect news from around the globe. Financial world news, market analysis, investment scam prevention tips and more.

info@newsforfinance.com